The Movement Disorder Journal and News

Neuralight's Eye-Movement Software and the MDS-UPDRS

In this episode, we sit down with Dr. Eitan Raveh, VP of Clinical Partnerships at NeuraLight, to explore a technology that could reshape how Parkinson's disease is measured and tracked in clinical trials. For nearly four decades, the MDS-UPDRS has been the gold standard for evaluating Parkinson's progression, but a new study suggests that a simple eye-tracking test, administered on a tablet in about ten minutes, may be more sensitive at detecting disease progression than the scale neurologists have relied on for generations. Dr. Raveh walks us through NeuraLight's landmark longitudinal study, what the Amplitude of Saccadic Hypometria actually measures, and why two of the scientists who helped build the MDS-UPDRS are now co-authors on a paper showing it may have met its match. If you follow Parkinson's research, drug development, or the future of digital biomarkers in neurology, this is a conversation you won't want to miss.

The Brutal Math of Parkinson’s Clinical Trials

In this episode, we explore the costs of clinical trials for both the patients and the drug companies, the risks that can come along with them, and the difficult balance between hope and uncertainty that exists in every study. We'll take a closer look at what it takes to bring a new treatment from the laboratory to the clinic, why so many promising therapies fail, and how the people who participate in clinical trials play a vital role in advancing medical science.

A Parkinson's Podcast with Dr. Homer Ferree

We cover the basics of Parkinson's Disease and Essential Tremor. Whether you've been diagnosed or have a friend or family member with the disease, this podcast is for you.

Parkinson's, Aging, and the Gut Microbiome

Researchers are now more than ever convinced that Parkinson's disease could start in the digestive tract years before symptoms could ever develop. In this episode, Dr. Julie Anderson and Dr. Minna Schmitt of the Buck Institute for Research and Aging explore the growing body of research connecting the gut, the brain, and Parkinson's disease, including the role of the microbiome, inflammation, and the gut-brain axis. We discuss what scientists are discovering, what it could mean for earlier diagnosis, and why gut health has become one of the most talked-about areas of Parkinson's research today.

TogetherForSharon®: Fighting Parkinson’s by Transforming Grief into Advocacy for Parkinson’s Awareness

After losing his mother, Sharon, to Parkinson’s disease, Dr. George Ackerman transformed personal tragedy into a nationwide advocacy movement. Through TogetherForSharon, he is working to raise awareness, educate communities, support research, and give a voice to families affected by Parkinson’s. This is a story about resilience, purpose, and how one family's loss became a source of hope for millions of others.